NVIC.org (@NVIC)
Posted
8 replies · 17 reposts · 13 likes
COVID Antiviral Paxlovid Provides “No Significant Benefit” to Vaccinated Seniors ☑️ Paxlovid’s High Cost vs. Low Impact: What the Data Shows for the Vaccinated ☑️ Pfizer’s Warns Paxlovid Risks Can Be ‘Severe, Life-Threatening, or Fatal’ ☑️ 1 in 5 Paxlovid Users Experience COVID Rebound Infections: 2023 Study READ MORE ▶️ https://ow.ly/U9QI50VlQP1 #COVID19 #Paxlovid #SeniorHealth #TheVaccineReaction #NVIC